BioNTech gibt Update zu Entwicklungsplänen für nachhaltige Lösungen gegen Infektionskrankheiten auf dem afrikanischen Kontinent
July 26, 2021 10:00 ET
|
BioNTech SE
BioNTech will den ersten mRNA-basierten Impfstoff zur Malaria-Prävention entwickeln und plant den Start einer klinischen Studie bis Ende 2022 BioNTech prüft nachhaltige Lösungen für...
Der Kampf gegen Infektionskrankheiten auf dem afrikanischen Kontinent
July 23, 2021 09:50 ET
|
BioNTech SE
Der afrikanische Kontinent kämpft gegen einen überproportional hohen Anteil der globalen Infektionskrankheiten. Die außerordentlichen wissenschaftlichen Fortschritte, die während der COVID-19-Pandemie...
Fighting Infectious Diseases on the African Continent
July 23, 2021 09:50 ET
|
BioNTech SE
The African continent carries a disproportionately high share of the global infectious disease burden. The extraordinary scientific progress made during the COVID-19 pandemic gives hope in addressing...
Canadian business and philanthropic leaders call on their peers to #ShareTheHealth and donate to UNICEF’s COVID-19 Global Vaccination Efforts
May 27, 2021 08:30 ET
|
UNICEF Canada
Toronto, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- Today, 16 senior leaders from top Canadian companies and foundations, including Teck Resources Limited and Fairmount Foundation, released an Open...
Global Smart Commodity Group Partners with Advanced Hemp Processing
April 28, 2021 14:00 ET
|
Global Smart Commodity Group
CHICAGO, April 28, 2021 (GLOBE NEWSWIRE) -- Global Smart Commodity Group (GSCG) is thrilled to be working with Advanced Hemp Processing (AHP) who is now GMP certified to Annex 2 WHO. With this...
Meningitis Canada Urges Policy Makers to Help Defeat Meningitis
April 23, 2021 09:00 ET
|
Meningitis Foundation
WATERLOO, Ontario, April 23, 2021 (GLOBE NEWSWIRE) -- This World Meningitis Day (April 24th), Meningitis Foundation Canada (MFC) is raising awareness of this ‘indiscriminate killer disease’ and...
BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator
November 15, 2020 19:35 ET
|
BioAegis Therapeutics
No drug-related safety signals identified by the independent Data and Safety Monitoring Board.MORRISTOWN, N.J., Nov. 15, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage,...
WHO Leader to Address CONV2X 2020
November 05, 2020 16:10 ET
|
Partners in Digital Health
STAMFORD, Conn., Nov. 05, 2020 (GLOBE NEWSWIRE) -- World Health Organization (WHO) Director - General Dr. Tedros Adhanom Ghebreyesus will address the 4th Annual ConVerge2Xcelerate (#CONV2X) 2020...
GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
October 26, 2020 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...
BioAegis Therapeutics Announces Study Indicating Gelsolin Treatment Improves Survival and Reduces Lung Injury in Antibiotic Resistant Pneumonia
September 03, 2020 21:42 ET
|
BioAegis Therapeutics
MORRISTOWN, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through...